BioPharma Company, CEO Hit With Investor Class Action Lawsuit
SEATTLE — Two shareholders of a pharmaceutical company that develops certain treatments for neurological diseases sued the company and its CEO in Washington federal court on June 25, alleging that the...To view the full article, register now.
Already a subscriber? Click here to view full article